J&J Covid-19 Vaccine Is 66% Effective in Global Clinical Trial

Health and WellBeing

Johnson & Johnson’s one-shot vaccine generated strong protection against Covid-19 in a large, late-stage trial, raising hopes that it can rapidly reshape a stumbling immunization campaign.

Credit Bloomberg Quicktake: Now